vs
STANDARD BIOTOOLS INC.(LAB)与NETSOL TECHNOLOGIES INC(NTWK)财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是NETSOL TECHNOLOGIES INC的1.0倍($19.6M vs $18.8M),NETSOL TECHNOLOGIES INC净利率更高(1.3% vs -177.4%,领先178.7%),NETSOL TECHNOLOGIES INC同比增速更快(21.1% vs -11.5%),NETSOL TECHNOLOGIES INC自由现金流更多($-5.1M vs $-23.1M),过去两年NETSOL TECHNOLOGIES INC的营收复合增速更高(10.3% vs -12.2%)
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
NETSOL科技公司是一家总部位于加利福尼亚州恩西诺的美国软件企业,核心业务为开发汽车租赁领域相关软件产品,为汽车租赁行业提供专业的数字化技术支持。
LAB vs NTWK — 直观对比
营收规模更大
LAB
是对方的1.0倍
$18.8M
营收增速更快
NTWK
高出32.5%
-11.5%
净利率更高
NTWK
高出178.7%
-177.4%
自由现金流更多
NTWK
多$18.0M
$-23.1M
两年增速更快
NTWK
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $19.6M | $18.8M |
| 净利润 | $-34.7M | $246.8K |
| 毛利率 | 48.5% | 48.0% |
| 营业利润率 | -168.5% | 6.9% |
| 净利率 | -177.4% | 1.3% |
| 营收同比 | -11.5% | 21.1% |
| 净利润同比 | -28.8% | 121.5% |
| 每股收益(稀释后) | $-0.09 | $0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LAB
NTWK
| Q4 25 | — | $18.8M | ||
| Q3 25 | $19.6M | $15.0M | ||
| Q2 25 | $21.8M | $18.4M | ||
| Q1 25 | $40.8M | $17.5M | ||
| Q4 24 | — | $15.5M | ||
| Q3 24 | $22.1M | $14.6M | ||
| Q2 24 | $22.5M | $16.4M | ||
| Q1 24 | $45.5M | $15.5M |
净利润
LAB
NTWK
| Q4 25 | — | $246.8K | ||
| Q3 25 | $-34.7M | $-2.4M | ||
| Q2 25 | $-33.5M | $2.6M | ||
| Q1 25 | $-26.0M | $1.4M | ||
| Q4 24 | — | $-1.1M | ||
| Q3 24 | $-26.9M | $70.8K | ||
| Q2 24 | $-45.7M | $-82.9K | ||
| Q1 24 | $-32.2M | $327.5K |
毛利率
LAB
NTWK
| Q4 25 | — | 48.0% | ||
| Q3 25 | 48.5% | 39.4% | ||
| Q2 25 | 48.8% | 56.2% | ||
| Q1 25 | 48.4% | 49.8% | ||
| Q4 24 | — | 44.5% | ||
| Q3 24 | 54.9% | 45.0% | ||
| Q2 24 | 46.1% | 51.5% | ||
| Q1 24 | 53.1% | 48.3% |
营业利润率
LAB
NTWK
| Q4 25 | — | 6.9% | ||
| Q3 25 | -168.5% | -12.2% | ||
| Q2 25 | -118.1% | 17.4% | ||
| Q1 25 | -80.8% | 8.9% | ||
| Q4 24 | — | -3.1% | ||
| Q3 24 | -120.9% | -5.2% | ||
| Q2 24 | -134.5% | 4.9% | ||
| Q1 24 | -132.2% | 8.5% |
净利率
LAB
NTWK
| Q4 25 | — | 1.3% | ||
| Q3 25 | -177.4% | -15.7% | ||
| Q2 25 | -153.7% | 14.0% | ||
| Q1 25 | -63.8% | 8.1% | ||
| Q4 24 | — | -7.4% | ||
| Q3 24 | -122.0% | 0.5% | ||
| Q2 24 | -203.3% | -0.5% | ||
| Q1 24 | -70.6% | 2.1% |
每股收益(稀释后)
LAB
NTWK
| Q4 25 | — | $0.02 | ||
| Q3 25 | $-0.09 | $-0.20 | ||
| Q2 25 | $-0.09 | $0.22 | ||
| Q1 25 | $-0.07 | $0.12 | ||
| Q4 24 | — | $-0.10 | ||
| Q3 24 | $-0.07 | $0.01 | ||
| Q2 24 | $-0.12 | $-0.01 | ||
| Q1 24 | $-0.27 | $0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $18.1M |
| 总债务越低越好 | — | $337.0K |
| 股东权益账面价值 | $399.7M | $35.9M |
| 总资产 | $539.6M | $62.7M |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势,按日历期对齐
现金及短期投资
LAB
NTWK
| Q4 25 | — | $18.1M | ||
| Q3 25 | $129.4M | $22.7M | ||
| Q2 25 | $158.6M | $17.4M | ||
| Q1 25 | $150.9M | $18.8M | ||
| Q4 24 | — | $21.3M | ||
| Q3 24 | $210.6M | $24.5M | ||
| Q2 24 | $269.8M | $19.1M | ||
| Q1 24 | $287.1M | $12.3M |
总债务
LAB
NTWK
| Q4 25 | — | $337.0K | ||
| Q3 25 | — | $218.2K | ||
| Q2 25 | — | $134.6K | ||
| Q1 25 | — | $86.8K | ||
| Q4 24 | — | $87.0K | ||
| Q3 24 | $55.2M | $92.6K | ||
| Q2 24 | $55.1M | $95.8K | ||
| Q1 24 | $55.0M | $130.4K |
股东权益
LAB
NTWK
| Q4 25 | — | $35.9M | ||
| Q3 25 | $399.7M | $35.8M | ||
| Q2 25 | $424.5M | $37.8M | ||
| Q1 25 | $454.6M | $35.5M | ||
| Q4 24 | — | $33.9M | ||
| Q3 24 | $489.3M | $34.7M | ||
| Q2 24 | $510.3M | $34.8M | ||
| Q1 24 | $577.3M | $35.3M |
总资产
LAB
NTWK
| Q4 25 | — | $62.7M | ||
| Q3 25 | $539.6M | $62.6M | ||
| Q2 25 | $557.0M | $62.4M | ||
| Q1 25 | $579.6M | $58.1M | ||
| Q4 24 | — | $59.1M | ||
| Q3 24 | $681.5M | $62.8M | ||
| Q2 24 | $708.7M | $64.2M | ||
| Q1 24 | $777.7M | $63.3M |
负债/权益比
LAB
NTWK
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | 0.11× | 0.00× | ||
| Q2 24 | 0.11× | 0.00× | ||
| Q1 24 | 0.10× | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $-4.7M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $-5.1M |
| 自由现金流率自由现金流/营收 | -118.1% | -27.2% |
| 资本支出强度资本支出/营收 | 4.5% | 2.0% |
| 现金转化率经营现金流/净利润 | — | -19.24× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $-1.0M |
8季度趋势,按日历期对齐
经营现金流
LAB
NTWK
| Q4 25 | — | $-4.7M | ||
| Q3 25 | $-22.2M | $5.3M | ||
| Q2 25 | $-20.7M | $441.0K | ||
| Q1 25 | $-30.3M | $-363.4K | ||
| Q4 24 | — | $-5.1M | ||
| Q3 24 | $-27.9M | $5.5M | ||
| Q2 24 | $-39.0M | $6.5M | ||
| Q1 24 | $-62.5M | $-4.2M |
自由现金流
LAB
NTWK
| Q4 25 | — | $-5.1M | ||
| Q3 25 | $-23.1M | $4.8M | ||
| Q2 25 | $-22.6M | $-44.1K | ||
| Q1 25 | $-35.3M | $-693.0K | ||
| Q4 24 | — | $-5.6M | ||
| Q3 24 | $-30.1M | $5.4M | ||
| Q2 24 | $-41.0M | $6.1M | ||
| Q1 24 | $-63.3M | $-4.6M |
自由现金流率
LAB
NTWK
| Q4 25 | — | -27.2% | ||
| Q3 25 | -118.1% | 32.1% | ||
| Q2 25 | -103.6% | -0.2% | ||
| Q1 25 | -86.6% | -4.0% | ||
| Q4 24 | — | -36.1% | ||
| Q3 24 | -136.4% | 37.1% | ||
| Q2 24 | -182.2% | 37.0% | ||
| Q1 24 | -138.9% | -29.6% |
资本支出强度
LAB
NTWK
| Q4 25 | — | 2.0% | ||
| Q3 25 | 4.5% | 3.2% | ||
| Q2 25 | 8.7% | 2.6% | ||
| Q1 25 | 12.4% | 1.9% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | 10.2% | 0.7% | ||
| Q2 24 | 8.6% | 2.6% | ||
| Q1 24 | 1.7% | 2.4% |
现金转化率
LAB
NTWK
| Q4 25 | — | -19.24× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.17× | ||
| Q1 25 | — | -0.26× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 77.94× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -12.84× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
NTWK
| Core Revenue | $18.0M | 96% |
| Other | $816.8K | 4% |